DaVita
DVA
#1670
Rank
S$16.42 B
Marketcap
S$255.93
Share price
3.72%
Change (1 day)
35.99%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): S$14.10

According to DaVita's latest financial reports the company's current EPS (TTM) is S$14.09. In 2025 the company made an earnings per share (EPS) of S$12.97 a decrease over its 2024 EPS that were of S$14.13.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$14.108.76%
2025S$12.97-8.25%
2024S$14.1344.94%
2023S$9.7527.26%
2022S$7.66-35.56%
2021S$11.8944.1%
2020S$8.2519.7%
2019S$6.89540.48%
2018S$1.08-76.07%
2017S$4.50-19.31%
2016S$5.57242.52%
2015S$1.63-62.87%
2014S$4.3813.43%
2013S$3.868.45%
2012S$3.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
S$31.15 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$14.56 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
S$24.92 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.47-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA